NICU GERD trial: which therapy helps babies feed better?
NCT ID NCT06114836
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares three approaches for treating GERD in NICU infants: letting the condition improve naturally, using the drug omeprazole, or using a special added rice formula. Researchers will track 369 babies to see which treatment leads to better feeding and fewer symptoms like vomiting or coughing. The goal is to find the safest and most effective way to manage GERD in these vulnerable infants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Omeprazole (a proton pump inhibitor) and added rice formula
- What this could lead to
- If this trial succeeds, it could show which GERD treatment works best for NICU infants, helping doctors choose the safest and most effective option.
- What could go wrong
- This is a single-center study with a relatively small sample size, so results may not apply to all infants. The treatments may not show clear differences, and side effects like digestive issues are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERD IN INFANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nationwide Children's Hospita
RECRUITINGColumbus, Ohio, 43215, United States